← Evidence map

ReviewFrontiers in oncology2014

Serglycin: at the crossroad of inflammation and malignancy.

Angeliki Korpetinou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

81 papers cite itlatest 60 shown

2014
…
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 24455486